ArticleDiagnostics (Basel, Switzerland)2022
An Ensemble of Transfer Learning Models for the Prediction of Skin Cancers with Conditional Generative Adversarial Networks.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 22 citations in OpenAlex.
- Skin cancer detection using late fusion of pretrained models.Scientific reports · 2026Article
- Explainable and secure federated learning for privacy-enhancing skin cancer classification using a lightweight multi-scale CNN.Scientific reports · 2026Article
- Explainable AI-Based Skin Cancer Detection Using CNN, Particle Swarm Optimization and Machine Learning.Journal of imaging · 2024Article
- Enhancing Dermatological Diagnostics with EfficientNet: A Deep Learning Approach.Bioengineering (Basel, Switzerland) · 2024Article
- Detection of Cervical Foraminal Stenosis from Oblique Radiograph Using Convolutional Neural Network Algorithm.Yonsei medical journal · 2024Article
- Challenges of Deep Learning in Cancers.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
Skin cancer is one of the most severe forms of the disease, and it can spread to other parts of the body if not detected early. Therefore, diagnosing and treating skin cancer patients at an early stage is crucial. Since a manual skin cancer diagnosis is both time-consuming and expensive, an incorrect diagnosis is made due to the high similarity between the various skin cancers. Improved categorization of multiclass skin cancers requires the development of automated diagnostic systems. Herein, we propose a fully automatic method for classifying several skin cancers by fine-tuning the deep learning models VGG16, ResNet50, and ResNet101. Prior to model creation, the training dataset should undergo data augmentation using traditional image transformation techniques and Generative Adversarial Networks (GANs) to prevent class imbalance issues that may lead to model overfitting. In this study, we investigate the feasibility of creating dermoscopic images that have a realistic appearance using Conditional Generative Adversarial Network (CGAN) techniques. Thereafter, the traditional augmentation methods are used to augment our existing training set to improve the performance of pre-trained deep models on the skin cancer classification task. This improved performance is then compared to the models developed using the unbalanced dataset. In addition, we formed an ensemble of finely tuned transfer learning models, which we trained on balanced and unbalanced datasets. These models were used to make predictions about the data. With appropriate data augmentation, the proposed models attained an accuracy of 92% for VGG16, 92% for ResNet50, and 92.25% for ResNet101, respectively. The ensemble of these models increased the accuracy to 93.5%. A comprehensive discussion on the performance of the models concluded that using this method possibly leads to enhanced performance in skin cancer categorization compared to the efforts made in the past.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.